Company / Current Assets
Vanda Pharmaceuticals Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$347.3M
FY2025
5-year range
$347.3M / $519.3M
FY2021-FY2025
Trend
-20.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $170M in FY2017 to $519M in FY2022.
Based on SEC 10-K filings.
$347M in FY2025 with a 5-year CAGR of -3.2%.
Declined from $433M to $347M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -12.6%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.2%, indicating a declining trend.
- In FY2025, current assets decreased 20.9% year-over-year.
- Peak current assets was recorded in FY2022.
- Lowest current assets in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $347.3M | -20.9% |
| FY2024 | $438.9M | +1.4% |
| FY2023 | $432.9M | -16.6% |
| FY2022 | $519.3M | +8.6% |
| FY2021 | $478.3M | +16.9% |
| FY2020 | $409.1M | +15.5% |
| FY2019 | $354.1M | +18.4% |
| FY2018 | $299.1M | +76.1% |
| FY2017 | $169.9M | -2.5% |
| FY2016 | $174.2M | +4.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026